Imprimis Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMMY and buy or sell other stocks, ETFs, and their options commission-free!About IMMY
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development.
CEOMark L. Baum
CEOMark L. Baum
Employees382
Employees382
HeadquartersNashville, Tennessee
HeadquartersNashville, Tennessee
Founded2006
Founded2006
Employees382
Employees382
IMMY Key Statistics
Market cap232.97M
Market cap232.97M
Price-Earnings ratio-300.59
Price-Earnings ratio-300.59
Dividend yield—
Dividend yield—
Average volume16.76K
Average volume16.76K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$50.72
52 Week high$50.72
52 Week low$20.85
52 Week low$20.85
Stock Snapshot
Imprimis Pharmaceuticals(IMMY) stock is priced at $6.29, giving the company a market capitalization of 232.97M. It carries a P/E multiple of -300.59.
On 2025-12-07, Imprimis Pharmaceuticals(IMMY) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Imprimis Pharmaceuticals(IMMY) stock has reached 0, versus its average volume of 16.76K.
Over the past 52 weeks, Imprimis Pharmaceuticals(IMMY) stock has traded between a high of $50.72 and a low of $20.85.
Over the past 52 weeks, Imprimis Pharmaceuticals(IMMY) stock has traded between a high of $50.72 and a low of $20.85.